Синдром раздраженного кишечника у пациента с ожирением: случайность или закономерность?
Аннотация
В обзорной статье изучаются механизмы двухнаправленной патогенетической коморбидности синдрома раздраженного кишечника и ожирения, особое внимание уделяется гормональному профилю, психосоматическим особенностям и количественно-качественным характеристикам микробиоты. Исследование механизмов коморбидности может быть целесообразным в плане более детального изучения патофизиологии и оптимизации терапии СРК и ожирения.
Ключевые слова
ожирение,
метаболический синдром,
синдром раздраженного кишечника,
психосоматика,
микробиота,
половые гормоны
Об авторах
В. И. Симаненков
ФГБОУ ВО «СевероЗападный государственный медицинский университет имени И. И. Мечникова» Минздрава России
Россия
Россия
С. В. Тихонов
ФГБОУ ВО «СевероЗападный государственный медицинский университет имени И. И. Мечникова» Минздрава России
Россия
Россия
В. Д. Декканова
ФГБОУ ВО «СевероЗападный государственный медицинский университет имени И. И. Мечникова» Минздрава России
Россия
Россия
М. К. Алиева
ФГБОУ ВО «СевероЗападный государственный медицинский университет имени И. И. Мечникова» Минздрава России
Россия
Россия
В. Р. Данилов
ФГБОУ ВО «СевероЗападный государственный медицинский университет имени И. И. Мечникова» Минздрава России
Россия
Россия
Список литературы
1. http://www. who.int/en Обращение от 22.11.2017.
2. Johonson D. A. Gastroenterologist issues in the obese patient. 2010; V: 548-557.
3. Eslick G. D. Gastrointestinal symptoms and obesity: a meta-analysis. Obesity Reviews 2012; 13 (5): 69-79.
4. Brian E., Fermin M., LinC et al. Exploring sales data during a healthy corner store intervention in Toronto: the Food Retail Environments Shaping Health (FRESH) project. Gastroenterology 2016;150: 1393-1407.
5. Ивашкин В. Т., Полуэктова Е.А. Сочетание синдрома функциональной диспепсии и синдрома раздраженного кишечника. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2011; 4: 75-81.
6. El-Salhy M. Recent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterobgy. 2015; 21(25): 21-36.
7. Prevalence and predictors of irritable bowel syndrome in patients with morbid obesity: a cross-sectional study.
8. Hogan A.M., Collins D., Baird A. W., Winter D. C. Estrogen and its role in gastrointestinal health and disease. J Colorectal Disease. 2009; 24(12): 67-75.
9. Wald A., Gavaler J.S., Egler K. M., et al. Gastrointestinal transit: the effect of the menstrual cycle. Gastroenterology. 1981; 80: 1497-1500.
10. Ryan J. P., Bhojwani A. Colonic transit in rats: effect of ovariectomy, sex steroid hormones, and pregnancy. J Physiology. 1986; 251: 46-50.
11. Shimomura A., Ohama T., Hori M., et al. 17 Beta-estradiol induces gastrointestinal motility disorder by decreasing CPI-17 phosphorylation via changes in rho-family G-protein end expression in small intestine. J Vet Med Sci. 2009; 71: 1591-1597.
12. Xie D., Chen L., Liu C. The inhibitory effects of oxytocin on distal colonic contractile activity in rabbits are enhanced by ovarian steroids. Physiology. 2006; 186: 141-149.
13. Wu C. L., Hung C. R., Chang F. Y., et al. Involvement of cholecystokinin receptor in the inhibition of gastric emptying by oxytocin in male rats. Pflugers Archiv European Journal of Physiology. 2002; 445: 187-193.
14. Xie D. P., Chen L. B., Liu C. Y., et al. Effect of oxytocin on contraction of rabbit proximal colon in vitro. World J Gastroenterology. 2003; 9: 165-168.
15. Li C. P., Ling C., Biancani P. Effect of progesterone on colonic motility and fecal output in mice with diarrhea. Neurogastroenterology and Motilit. 2012; 24: 392-394.
16. Liu C. Y., Chen L. B., Liu P. Y., et al. Effects of progesterone on gastric emptying and intestinal transit in male rats. World J Gastroenterology. 2002; 8: 338-341.
17. Xiao Z. L., Pricolo V., Biancani P. Role of progesterone signaling in the regulation of G-protein levels in female chronic constipation. Gastroenterology. 2005; 128: 667-675.
18. Longstreth G. F., Thompson W. G., Chey W. D., et al. Functional bowel disorders. Gastroenterology. 2006; 130 (5): 80-91.
19. Bashaw M. J., Pathak D. R., Moody S. M., et al. An overlooked connection: serotonergic mediation of estrogen-related physiology and pathology. BMC Womens Health. 2005; 5: 12-13.
20. Niesler B., Kapeller J., Fell C., et al. 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene and irritable bowel syndrome: effect of bowel habit and sex. J Gastroenterol Hepatol. 2010; 22 (7): 56-61.
21. Mizuno T., Aoki M., Shimada Y., et al. Gender difference in association between polymorphism of serotonin transporter gene regulatory region and anxiety. J Psychosom Res. 2006; 60 (1): 1-7.
22. Pecins-Thompson M., Brown N. A., Bethea C. L., et al. Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Brain Res Mol Brain Res. 1998; 53: 120-129.
23. Gundlah C., Lu N. Z., Bethea C. L. Ovarian steroid regulation of monoamine oxidase-A and-B mRNAs in the macaque dorsal raphe and hypothalamic nuclei. Psychopharmacology (Berl) 2002; 160: 271-282.
24. Smith L. J., Henderson J. A., Abell C. W. Effects of ovarian steroids and raloxifene on proteins that synthesize, transport, and degrade serotonin in the raphe region of macaques. Neuropsychopharmacology. 2004; 29: 2035-2045.
25. Gershon M.D, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology. 2007; 132: 397-414.
26. Mulak A., Tache Y. Sex difference in irritable bowel syndrome: do gonadal hormones play a role? Gastroenterol Pol. 2010; 17: 89-97.
27. Morford JJ., Wu S., Mauvais-Jarvis F. The impact of androgen actions in neurons on metabolic health and disease. J Mol Cell Endocrinology. 2017; 4: 3-9.
28. Bray G. A. Contemporary diagnosis and management of obesity. Handbooks in Health Care CO. 2000; 5: 288-289.
29. Haffner S. M., Fong D., Hazuda H. P. et al. Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics. J Metabolism. 1988; 37: 338-345.
30. Кондрашкина О. В., Ермачек Е.А., Кривцова Е. В., и др. Особенности гормонального метаболизма у мужчин, больных ожирением. РМЖ. 2007; 2: 84-85.
31. Mulak A., Tache Y., Larauche M. Sex hormones in the modulation of irritable bowel syndrome. World J. Gastroenterol. 2014; 20(10): 2433-2448.
32. Rybaczyk L. A., Bashaw M.J., Pathak D. R. et al. An overlooked connection: serotonergic mediation of estrogen-related physiology and pathology. BMC Womens Health. 2005; 5: 11-12.
33. Tache Y., Bonaz B. Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. J Clin Invest. 2007; 117: 33-40.
34. Cremon C., Gargano L., Morselli-Labate A.M., et al. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol. 2009; 104:392-400.
35. Александровский Ю. А., Вышковский Г. Л. Энциклопедия психиатрии: Руководство для практикующих врачей. М., 2003; 545-546.
36. Елфимова Е. В., Елфимов М. А., Березкин А. С. Психосоматические взаимоотношения при заболевании желудочнокишечного тракта на модели синдрома раздраженного кишечника. Экспериментальная и клиническая гастроэнтерология. 2015; 4: 83-88.
37. Sang H. R., Emeran A. M. Principles and clinical implications of the brain-gut-enteric microbiota axis. Gastroenterol Hepatol. 2009;6 (5): 14-16.
38. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and ß-endorphin. Science. 1981; 213: 1394-1397.
39. Hauger R. L., et al. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands. Pharmacol. Rev. 2003; 55: 21-26.
40. Hillhouse E. W., Grammatopoulos D. K. The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr. Rev. 2006; 27:260-286.
41. Tache Y., Bruno B. Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. The Journal of Clinical Invistigation. 2007; 117 (1): 33-40.
42. Monnikes H., Schmidt B. G., Raybould H. E. CRF in the paraventricular nucleus mediates gastric and colonic motor response to restraint stress. Am. J. Physiol. 1992; 262: 137-143.
43. Bueno L., Fioramonti J. Effects of corticotropin-releasing factor, corticotropin and cortisol on gastrointestinal motility in dogs. J Peptides. 1986; 7: 73-77.
44. Lenz H. J., Raedler A., Greten H., et al. Stress-induced gastrointestinal secretory and motor responses in rats are mediated by endogenous corticotropin-releasing factor. Gastroenterology. 1988; 95: 1510-1517.
45. Tache Y., Perdue M. H. Role of peripheral CRF signaling pathways in stress-related alterations of gut motility and mucosal function. Neurogastroenterol. Motil. 2004; 16 (1): 1-6.
46. Kihara N., et al. Effects of central and peripheral urocortin on fed and fasted gastroduodenal motor activity in conscious rats. Am. J. Gastrointest. Liver Physiol. 2001; 280: 406-419.
47. Porcher C., et al. Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum. J Peptides. 2006; 27: 1464-1475.
48. Martinez V., Wang L., Rivier J.E., et al. Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2. J. Pharmacol. Exp. Ther. 2002; 301: 611-617.
49. Fukudo S., Nomura T., Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. J Gut. 1998; 42:845-849.
50. Dallman M. F. Stress-induced obesity and the emotional nervous system. Trends Endocrinol Metab. 2010; 21 (3): 159-165.
51. Roozendaal B, McEwen B.S, Chattarji S. Stress, memory and the amygdala. Nature Reviews Neuroscience. 2009; 10 (6): 32-33.
52. Roozendaal B., Schelling G., McGaugh J. L. Corticotropin-releasing factor in the basolateral amygdala enhances memory consolidation via an interaction with the beta-adrenoceptor-cAMP pathway: dependence on glucocorticoid receptor activation. J Neurosci. 2008; 28 (26): 49-51.
53. Schwabe L., Wolf O. T. Stress prompts habit behavior in humans. J Neurosci. 2009; 29 (22): 7-8.
54. Dallman M. F., Pecoraro N., Akana S. F. Chronic stress and obesity: a new view of «comfort food». Proceedings of the National Academy of Sciences U S A. 2003; 100 (20): 696-701.
55. Creswell J.D., Way B.M., Eisenberger N. I., et al. Neural correlates of dispositional mindfulness during affect labeling. Psychosom Med. 2007; 69 (6): 56-60.
56. Bailey M. T., Coe C. L. Maternal separation disrupts the integrity of the intestinal microflora in infant rhesus monkeys. Dev. Psychobiol. 1999; 35: 146-155.
57. Macfarlane S, Dillon J.F. Microbial biofilms in the human gastrointestinal tract. J. Appl. Microbiol. 2007; 102: 1187-1196.
58. Barbara G, et al. Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am. J. Gastroenterol. 2005; 100: 2560-2568.
59. Dass N.B, et al. The relationship between the effects of short-chain fatty acids on intestinal motility in vitro and GPr43 receptor activation. Neurogastroenterol. Motil. 2007; 19: 66-74.
60. Malbert C. H. The ileocolonic sphincter. Neurogastroenterol. Motil. 2005; 17 (1): 41-49.
61. Nealson K. H., Platt T., Hastings J. W. Cellular control of the synthesis and activity of the bacterial luminescent system. J. Bacteriol. 1970; 104: 313-322.
62. Roth J., et al. Molecules of intercellularcommunication in vertebrates, invertebrates and microbes: do they share common origins? Prog. Brain Res. 1986; 68: 71-79.
63. Hughes D. T., Sperandio V. Inter-kingdom signalling: communication between bacteria and their hosts. Nat. Rev. Microbiol. 2008; 6: 111-120.
64. Sperandio V., Torres A. G., Nataro J. P. Bacteria -host communication: the language of hormones. Proceedings of the National Academy of Sciences USA. 2003; 100: 8951-8956.
65. Walsh J. H., Mayer E. A. Gastrointestinal peptide hormones and signal transduction. J Gastrointestinal Disease: Pathophysiology, Diagnosis, Management. 1993; 11: 18-44.
66. Курмангулов А. А., Дороднева Е. Ф., Исакова Д. Н. Функциональная активность микробиоты кишечника при метаболическом синдроме. Ожирение и метаболизм. 2016; 13 (1): 16-19.
67. Захаренко С. М., Фоминых Ю. А., Мехтиев С. Н. Микробиота кишечника человека и метаболический синдром. Эффективная фармакотерапия. Гастроэнтерология. 2011; 3: 14-22.
68. Li H., Qiu T.,, Huang G., et al. Production of gamma-aminobutyric acid by Lactobacillus brevis NCL912 using fed-batch fermentation. Microbifl cell factories. 2010; 9: 85-86.
69. Cho Y. R., Cho J. Y., Chang H. C. Production of gamma-aminobutyric acid (GABA) by Lactobacillus buchneri isolated from kimchi and its neuroprotective effect on neuronal cells. J. Microbiol. Biotechnol. 2007; 17 (1); 104-109.
70. Luo J.et al. Ingestion of Lactobacillus strain reduces anxiety and improves cognitive function in the hyperammonemia rat Sci. China. Life. Sci. 2014; 57 (3): 32-33.
71. Kalueff A. V., Nutt D. J. Role of GABA in anxiety and depression. Depression and Anxiety. 2007; 7: 495-517.
Рецензия
Для цитирования:
Симаненков В.И., Тихонов С.В., Декканова В.Д., Алиева М.К., Данилов В.Р. Синдром раздраженного кишечника у пациента с ожирением: случайность или закономерность? Медицинский алфавит. 2017;4(40):5-12.
For citation:
Simanenkov V.I., Tikhonov S.V., Dekkanova V.D., Alieva M.K., Danilov V.R. Irritable bowel syndrome in a patient with obesity: acident or regularity? Medical alphabet. 2017;4(40):5-12. (In Russ.)
Просмотров:
373
Послать статью по эл. почте 